Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

A Mini-Review on Marine Bioactive Compounds as a Source of Antiviral Drug Lead

Author(s): Ghanshyam Parmar*, Jay Mukesh Chudasama, Vaidehi Shah, Ashish P. Shah and Ashish Patel

Volume 9, Issue 5, 2023

Published on: 25 October, 2022

Article ID: e170822207568 Pages: 4

DOI: 10.2174/2215083808666220817095619

Price: $65

Abstract

Currently, pathogens or some microorganisms that are dangerous to human society cause plenty of diseases. All these diseases are spreading because of the limited available treatment options. Some pathogens species are very dangerous to humankind, particularly viral pathogens. These viral pathogens (viruses) have become resistant and immune to many of the medications, thus requiring more and more drug molecules or treatments to be discovered. Many new drugs or treatments are discovered and under clinical trials, and many are being tested. Presently, researchers are in continuous search of newer drugs or molecules using synthetic chemistry or exploring natural resources. However, synthesizing a drug molecule is time-consuming and requires more workforce and much more costly equipment. To tackle this challenge, the use of computational approaches provided complementary information that may also help in the discovery of new molecules. Recently, the fragment molecular orbit based density-functional tight-binding method (DFTB) of drug discovery of drug-like lead is rapid and accurate as compared to conventional computational approaches. Natural resources from land and water can become a choice as an alternative option to discover new entities. The marine environment provides us with a broad spectrum of chemically diverse antiviral compounds isolated from many marine organisms such as bacteria, fungi, sponges, algae, etc. Now, the natural marine molecule as an antiviral agent harrows a new way to modern medicine.

Keywords: Antiviral Agent, Marine Natural Molecule, Marine Organisms, Bacteria, Fungi, Sponge

Graphical Abstract

[1]
Uzair B, Mahmood Z, Tabassum S. Antiviral activity of natural products extracted from marine organisms. Bioimpacts 2011; 1(4): 203-11.
[PMID: 23678429]
[2]
Yasuhara-Bell J, Lu Y. Marine compounds and their antiviral activities. Antiviral Res 2010; 86(3): 231-40.
[http://dx.doi.org/10.1016/j.antiviral.2010.03.009] [PMID: 20338196]
[3]
Allec SI, Sun Y, Sun J, Chang C-A, Wong BM. Heterogeneous CPU. Heterogeneous CPU+GPU-enabled simulations for DFTB molecular dynamics of large chemical and biological systems. J Chem Theory Comput 2019; 15(5): 2807-15.
[http://dx.doi.org/10.1021/acs.jctc.8b01239] [PMID: 30916958]
[4]
Bhattacharya S, Asati V, Mishra M, Das R, Kashaw V, Kashaw SK. Integrated computational approach on sodium-glucose co-transporter-2 (SGLT2) Inhibitors for the development of novel antidiabetic agents. J Mol Struct 2021; 1227: 129511.
[http://dx.doi.org/10.1016/j.molstruc.2020.129511]
[5]
Magarvey NA, Keller JM, Bernan V, Dworkin M, Sherman DH. Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol 2004; 70(12): 7520-9.
[http://dx.doi.org/10.1128/AEM.70.12.7520-7529.2004] [PMID: 15574955]
[6]
Prudhomme J, McDaniel E, Ponts N, et al. Marine actinomycetes: A new source of compounds against the human malaria parasite. PLoS One 2008; 3(6): e2335.
[http://dx.doi.org/10.1371/journal.pone.0002335] [PMID: 18523554]
[7]
Arena A, Maugeri TL, Pavone B, Iannello D, Gugliandolo C, Bisignano G. Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int Immunopharmacol 2006; 6(1): 8-13.
[http://dx.doi.org/10.1016/j.intimp.2005.07.004] [PMID: 16332508]
[8]
Arena A, Gugliandolo C, Stassi G, et al. An exopolysaccharide produced by Geobacillus thermodenitrificans strain B3-72: Antiviral activity on immunocompetent cells. Immunol Lett 2009; 123(2): 132-7.
[http://dx.doi.org/10.1016/j.imlet.2009.03.001] [PMID: 19428560]
[9]
Gustafson KR, Cardellina JH II, Fuller RW, et al. AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae). J Natl Cancer Inst 1989; 81(16): 1254-8.
[http://dx.doi.org/10.1093/jnci/81.16.1254] [PMID: 2502635]
[10]
Mayer AM, Hamann MT. Marine pharmacology in 1999: Compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol 2002; 132(3): 315-39.
[http://dx.doi.org/10.1016/S1532-0456(02)00094-7] [PMID: 12161166]
[11]
Bugni TS, Ireland CM. Marine-derived fungi: A chemically and biologically diverse group of microorganisms. Nat Prod Rep 2004; 21(1): 143-63.
[http://dx.doi.org/10.1039/b301926h] [PMID: 15039840]
[12]
Rowley DC, Kelly S, Kauffman CA, Jensen PR, Fenical W, Halovirs A-E. Halovirs A-E, new antiviral agents from a marine-derived fungus of the genus Scytalidium. Bioorg Med Chem 2003; 11(19): 4263-74.
[http://dx.doi.org/10.1016/S0968-0896(03)00395-X] [PMID: 12951157]
[13]
Singh SB, Zink DL, Goetz MA, Dombrowski AW, Polishook JD, Hazuda DJ. Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as inhibitors of HIV-1 integrase. Tetrahedron Lett 1998; 39(16): 2243-6.
[http://dx.doi.org/10.1016/S0040-4039(98)00269-X]
[14]
Sagar S, Kaur M, Minneman KP. Antiviral lead compounds from marine sponges. Mar Drugs 2010; 8(10): 2619-38.
[http://dx.doi.org/10.3390/md8102619] [PMID: 21116410]
[15]
Loya S, Rudi A, Kashman Y, Hizi A. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases. Biochem J 2002; 362(Pt 3): 685-92.
[http://dx.doi.org/10.1042/bj3620685] [PMID: 11879196]
[16]
Lira SPd, Seleghim MH, Williams DE, et al. A SARS-coronavirus 3CL protease inhibitor isolated from the marine sponge Axinella cf. corrugata: Structure elucidation and synthesis. J Braz Chem Soc 2007; 18(2): 440-3.
[http://dx.doi.org/10.1590/S0103-50532007000200030]
[17]
Mayer AM, Hamann MT. Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol (NY) 2004; 6(1): 37-52.
[http://dx.doi.org/10.1007/s10126-003-0007-7] [PMID: 14583811]
[18]
Mollica A, Locatelli M, Stefanucci A, Pinnen F. Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems. Molecules 2012; 17(5): 6083-99.
[http://dx.doi.org/10.3390/molecules17056083] [PMID: 22614862]
[19]
Locatelli M, Governatori L, Carlucci G, Genovese S, Mollica A, Epifano F. Recent application of analytical methods to phase I and phase II drugs development: A review. Biomed Chromatogr 2012; 26(3): 283-300.
[http://dx.doi.org/10.1002/bmc.1674] [PMID: 21853452]
[20]
Longeon A, Copp BR, Quévrain E, et al. Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp. Mar Drugs 2011; 9(5): 879-88.
[http://dx.doi.org/10.3390/md9050879] [PMID: 21673896]
[21]
Tasdemir D, Bugni TS, Mangalindan GC, Concepción GP, Harper MK, Ireland CM. New bromotryptophan derivatives from the Philippine marine sponge Smenospongia sp. Z Naturforsch C J Biosci 2002; 57(9-10): 914-22.
[http://dx.doi.org/10.1515/znc-2002-9-1027] [PMID: 12440734]
[22]
Reyes F, Fernandez R, Rodriguez A, et al. Aplicyanins A–F, new cytotoxic bromoindole derivatives from the marine tunicate Aplidium cyaneum. Tetrahedron 2008; 64: 5119-23.
[http://dx.doi.org/10.1016/j.tet.2008.03.060]
[23]
Walker SR, Carter EJ, Huff BC, Morris JC. Variolins and related alkaloids. Chem Rev 2009; 109(7): 3080-98.
[http://dx.doi.org/10.1021/cr900032s] [PMID: 19489543]
[24]
Mayer AM, Rodríguez AD, Berlinck RG, Hamann MT. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim Biophys Acta 2009; 1790(5): 283-308.
[http://dx.doi.org/10.1016/j.bbagen.2009.03.011] [PMID: 19303911]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy